Abstracts Presented at Meetings July 1, 2001 June 30, 2004

Abstracts Presented at Meetings July 1, 2001 – June 30, 2004

Abu-Orf, M., J. Brewster, J.A. Oleszkiewicz, K.M. Coombs, R.S. Reimers, P. Lagasse, B. Amy, and D. Glindmann. (2003). Production of class A biosolids with anoxic low dose alkaline treatment and odor management.

Aidara-Kane A., S.M. DeLong, T.M. Chiller, J.A. Wagenaar, H.C. Wegener, L.-K. Ng, M. Jouan, F.J. Angulo and WHO Global Salm-Surv. World Health Organization Global Salm-Surv: working to reduce foodborne disease globally. ICEID meeting, Georgia, Atlanta, February 28-March 5, 2004.

Alfa MJ, DeGagne P, Nagy R, Harding GKM. Correlation of PFGE profile and antibiotic susceptibility profile for MRSA strains. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003.

Alfa MJ. Routine Cleaning Methods for Reprocessing of Triple-lumen Sphinctertomes that are SUDs may leave patient-material in the wire channel. Presented at the CACMID 2001 Conference in Victoria, B.C., Nov. 4 - 8, 2001.

Alfa, M, Hoban S, Nagy R, Harding GKM. Ward screening for MRSA: Optimization of sample collection. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003.

Alimonti JB, Kimani J and Fowke KR. Determination of CD4+ T Lymphocyte HIV-1 p24 Epitope Specificity in HIV Resistance. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada.

Alimonti JB, Kimani J, Matu L, Mwenga C, Plummer FA and Fowke KR. HIV-1 Resistant Commercial Sex Workers have a HIV-specific CD4+ T cell Response. Molecular Mechanisms of HIV Pathogenesis Keystone Symposia, April 12-18, 2004 Whistler, B.C.

Allen J, Clark CG, Woodward DL, Tabor HA, Foster R, Rodgers FG. Extension of the PCR-RFLP method for determining O-serogroups of Escherichia coli. American Society for Microbiology Annual General Meeting, Salt Lake City, Utah, May 2002

Amiali, M.N., Mulvey, M.R., Berger-Bachi, B., Louie, L., Ismail, A.A., Somorjai, R.L., Simor, A.E. evaluation of fourier transform infrared (FTIR) spectroscopy for the accurate identification of coagulase-negative Staphylococci (CNS) and methicillin-resistant CNS (MRCNS). 42rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, Sept. 14-17, 2002.

Amiali, M.N., Mulvey, MR, Ismail, A.A. Somorjai, R.L., Simor, A.E. Evaluation of Fourier Transform Infrared (FTIR) Spectroscopy for Epidemiological Typing of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Dec. 15-19, 2001.

Andonov A., M. Morbey and J. Rochefort. Performance characteristics of INNO-LIA HCV III Update Assay for confirmation of HCV antibodies. 2003; 72nd Annual CACMID (Canadian Association for Clinical Microbiology and Infectious Diseases) Meeting, November 2-5, 2003, Montreal.

Ao Z-j, N. Rougeau, E.A. Cohen, and X-J Yao. Generation and characterization of an HIV-1 single-cycle replication system, a potential vaccine for the control of HIV-1/AIDS. Second Annual Scientific Meeting of Canadian Vaccine Networks (CANVAC), Sainte Adele, Quebec, March 8 to 11, 2002.

Ao Z-j, X-J Yao and E.A. Cohen. Assessment of the role of the central DNA flap in HIV-1 single-cycle infection systems. Retroviruses Meeting, Cold Spring Harbor. New York. May 20 - 25, 2003.

Ao Z-j, X-J Yao and E.A. Cohen. Assessment of the role of the central DNA flap in HIV-1 replication using single-cycle infection systems. CAHR 2004: Translation of Science into Health. 13th Annual Canadian Conference on HIV/AIDS Research. Montreal, Quebec. May 13-16, 2004.

Aoki FY, Macleod MD, Paggiaro P, Wat C, Waalberg E, Ward P on behalf of the IMPACT Study Group. Early administration of oral oseltamivir maximizes the benefits of influenza treatment. International Congress of Chemotherapy, June 30-July 3, 2001, Amsterdam.

Aoki FY, Peterson S, Black C. Pharmacoepidemiology of Herpes zoster treatment with antiviral drugs in Manitoba: a population-based study, 1996-2001. 25th Anniversary Meeting of the Canadian Society for Clinical Pharmacology, September 19-21, 2003, Ottawa.

Ariano R, Nylan A, Donnelly J, Harding G, Zelenitsky S, Sitar D. Population pharmacokinetics of meropenem in febrile neutropenics using NPEM and optimal sampling design. Presented at the American Society of Clinical Pharmacology and Therapeutics. Washington, DC. March 2003.

Ariano RE, Franczuk C, Fine A, Harding GKM, Zelenitsky SA. Peritoneal Dialysis-Related Staphylococcus epidermidis Peritonitis: the Effect of Methicillin Resistance on Clinical Outcome. Presented at the 41st ICAAC. Chicago, IL. September 22-25, 2001.

Ariano, RE, Nyhlen A, Donnelly JP, Sitar DS, Harding GKM, Zelenitsky SA. The Pharmacodynamics (PD) of Meropenem in Febrile Neutropenic with Bacteremia. Presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL. September 14 – 17, 2003.

Artsob H, Drebot M, Dibernardo A, Ogden J, Baikie M, Maloney R, Goltz J, Whitney H, Lindsay R. 2003. Ixodes scapularis and its associated pathogens in Atlantic Canada. American Society of Tropical Medicine and Hygiene 52nd Annual Meeting, December 3-7, Philadelphia, Pennsylvania.

Artsob H, Kuno G, Karabatsos N, Tsuchiya KR, Chang JJ, Drebot MA. (2001) Phylogenetic studies on Powassan and deer tick virus isolates. 2001 International Northwest Conference on Diseases in Nature Communicable to Man, 56th Annual Meeting, July 29-August 1, Winnipeg, Manitoba.

Artsob H, Kuno G, Karabatsos N, Tsuchiya KR, Chang JJ, Fearon M, Drebot MA. (2001). Powassan virus: phylogenetic studies from a Canadian perspective. 2001 Conjoint Meeting, Canadian Association of Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.

Artsob H, Lindsay R, Buck P, Sockett P, Drebot M. 2004. Arbovirus activity in Canada. 2nd International Congress on Dengue and Yellow Fever. May 31-June 3, Havana, Cuba.

Artsob H, Lindsay R, Dibernardo A, Dick D, Holloway K, Drebot M. 2001. Hantavirus activity in Canada: an overview. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.

Artsob H, Lindsay R, Dibernardo A, Dick D, Holloway K, Shead S, Drebot,M. 2003. Hantavirus activity in Canada: 1989-2002. Annual Meeting of the Southwest Conference on Diseases in Nature Transmissible to Man, June 25-27, Amarillo, Texas.

Artsob H, MacPherson D, Feldmann H. 2001. Viral hemorrhagic fever scare in Hamilton, Ontario, February, 2001. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.

Artsob H. 2002. Introductory comments as Chairperson of Symposium entitled Update on Emerging Infectious Diseases, Canadian Association for Clinical Microbiology and Infectious Diseases, November 3-6, Halifax, Nova Scotia.

Artsob H. 2002. President’s welcoming remarks. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver, British Columbia.

Artsob H. 2003. Considerations for managing West Nile virus: 2003 and beyond. National West Nile Review and Planning Meeting, January 7-8, Ottawa, Ontario.

Bailey RC, Moses S, Agot K, Ndinya-Achola JO. Randomized, controlled trial of male circumcision in Kisumu, Kenya: preliminary baseline results [Abstract 1098727]. XIII International Conference on AIDS and STIs in Africa (ICASA), Nairobi, Kenya, September 21-26, 2003

Bailey RC, Okamo PL, Oroko EM, Ndinya-Achola JO, Moses S. The feasibility of a randomized controlled trail of male circumcision to reduce HIV incidence in Kisumu, Kenya [Abstract ThPeC7407]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002

Ball TB, Kimani J, Embree JE, Bwayo JJ, Plummer FA, Hayglass KT. Systemic levels of type-1 (IP-10 and MIG), and type-2 (TARG, MDC and EOTAXIN) chemokines in HIV-1 highly exposed, persistently seronegative (HEPS) and HIV infected sex workers from Nairobi, Kenya. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 125)

Barker I, Lindsay R, Drebot M, Buck P, Artsob H. 2003. West Nile: surveillance and response to an emerging disease in North America. 3rd International Veterinary Vaccines and Diagnostics Conference, July 13-18, Guelph, Ontario.

Barker IK, Drebot M, Artsob H, Lindsay LR, Buck P, Meyers R, Leighton F, Templeman R, Dallaire A, Daoust P-Y. 2002. Enhanced passive surveillance for West Nile virus in dead birds in Canada - 2001. 51st Annual Meeting of the Wildlife Disease Association, July 28- August 1, Davis, California.

Bastien, N, Ward, D, Van Caeseele, P, Brandt, K, Lee, S, McNabb, G, Klisko, and Li, Y. (2003). Prevalence of human metapneumovirus infection in Canada. XII International Conference on Negative strand viruses. Pisa, Italy.

Bastien, N., Normand, S., Brown, T., Ward, D., Peret,T.C., Boivin, G., Erdman, D.D., and Anderson, L.J., and Li, Y. (2002). Molecular characterization of the N, P, M, and F genes of human metapneumovirus isolated in Canada, XIIth International Congress of Virology, Paris, France.

Bastien, N., Ward, D., Hamilton, M., Bowness, D., Norman,s., and Li, Y. (2001). Antigenic and genetic characterization of influenza A H1N1 virus isolates circulating in Canada during the 1999-2000 influenza season. 20th Annual Meeting of the American Society for Virology, Madison, Wisconsin.

Bastien. N., Normand. S., Taylor. T., Ward. D., Peret.T.C., Boivin. G., Erdman. D.D. and Anderson. J.J., and Li. Y. (2002). Molecular characterization of human metapneumovirusisolated in Canada. Health Canada Research Forum: From Science to Policy. Ottawa.

Baydack, R. ,Jackson, M., Booth, T. Dubois, J., and McKenzie, E. (2002) Infrared microspectroscopic studies of transmissible spongiform encephalopathies in rodents. Pittcon, 17-22 March, New Orleans.

Becker M, Orr P, Nicolle L. Metastatic Infection with Fluoroquinolone-Resistant (FR) Streptococcus pneumoniae (Spn) following Levofloxacin (L) Treatment of Fluoroquinolone-Susceptible (FS) Spn. Resident Research Day, Department of Medicine, University of Manitoba, April 13, 2004.

Becker, M. L., A. A. Suchak, R. Zarychanski, J. N. Wolfe, C. Turenne, and A. Kabani,. Mycobacterium neoaurum Bacteremia in a Hemodialysis Patient. Can. J. Infect. Dis. Canadian Association for Clinical Microbiology and Infectious Diseases, Victoria. November 2001.

Bellas J, Wayne S, Ball TB*, Embree JE, and Fowke KR. A polymorphism of the CD4 molecule is associated with increased risk of HIV infection. Canadian Association for HIV Research Annual Meeting April 25-28 2002, Winnipeg, Canada.

Belletrutti P, Patry D, Sevick R, Tilley P, Mubareka S, Orr P, Holton D, Houston S, Williams K, McClean K, Conly J. Outbreak of West Nile Virus in the Prairie Provinces in the Summer of 2003: Clinical and Radiographic Features. Canadian Infectious Disease Society Meeting, Alberta, April 30, 2004.

Bellyou T, Palatnick L, Rimmer E, Nichol K, Zhanel GG and Hoban DJ. Incidence of penicillin doxycycline macrolide and fluoroquinolone resistant Streptococcus pneumoniae (SPN) in Canada: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS) 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.

Benes R., C.liu, E. Becker and Gehua Wang*. 2002. Association between Enterohemolysin2 (ehl2) Gene of Escherichia coli with Shiga Toxin Genes (stx). CACMID.

Bernard K, Artsob H, Fearon M. 2003. Creating a Canadian network of microbiology laboratories for bioterrorism (BT) response. ASM Biodefence Research Meeting, March 9-12, Baltimore, Maryland.

Bernard K, Artsob H, Shuttleworth L, Martin K, Fearon M. 2003. A training program for Tier 1 laboratories for recognition of the bacterial agents of bioterrorism. Canadian Association for Clinical Microbiology and Infectious Diseases, November 2-5, Montreal, Quebec.

Bernard K, Fearon M, Artsob H, Heisz M, Tepper M, The Health Canada Working Group. 2001. Response to agents of bioterrorism (BT) by Canadian laboratories: an update from the Health Canada working group. Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.

Bernard K. and H. Artsob (Health Canada, Winnipeg MB), M. Fearon (Prov Lab, Toronto Ont) for the BT Subcommittee CPHLN. Creating a Canadian Network of Microbiology Laboratories for Bioterrorism (BT) Response. ASM Biodefence Research Conference March 10-13, 2003 Baltimore MD.

Bernard K. et al, Health Canada Winnipeg Canada and H. Marchandin, et al. Montpellier, France. Proposal of ‘Dialister microaerophilus’ sp nov, a microaerophilic, Gram negative coccobacillus recovered from human clinical materials in France and Canada. 103rd ASM General Meeting. Washington DC May 2003.

Bernard K. et al. The use of the BIOTER data library as adjunct to the characterization of bacterial agents of bioterrorism. 102st ASM General Meeting, May 2002 Salt Lake City, Utah abstract no.C-13

Bernard K., L.De Winter and C. Munro. Coryneform taxa recovered from human clinical specimens. May 27 2004. 104th ASM Meeting, New Orleans, LA.

Bernard K.1*, H. Artsob, L. Shuttleworth Health Canada (HC) National Microbiology Laboratory (NML) Winnipeg MB, K. Martin, Centres for Emergency Preparedness and Response (CEPR) HC, Ottawa and M. Fearon PHL Toronto Ontario Ministry of Health. A training programme for Tier 1 laboratories for recognition of the bacterial agents of Bioterrorism 71st CACMID meeting, Montreal, Que. Nov. 4 2003.

Berry, J.D., Bratic, J., Clavijo, A., P Kitching. (2003) Development of cross-reactive, neutralizing murine mAbs to Foot-and-mouth disease virus. IBC Antibody Engineering, San Diego, Dec. 1-4th.

Berry, J.D., Licea, A., Popkov, M., C.F. Barbas, III. (2002) Rapid generation of monoclonal antibodies by in vivo targeting of Dendritic cells. Basic Aspects of Vaccines, 8th Annual National Symposium. Uniformed Services University of the Health Sciences, Bethesda, MD. May 13.

Berry, J.D., Rutherford, J., Barbas, III, C.F., and F. Plummer. (2001) IgA+B cells of highly exposed humans as a novel source of therapeutic antibodies. Med. Micro. and Infect. Dis. Retreat.Hecla Island. June 29-July 1.

Berry, J.D., Tsang, R., Yuan, X., Lisa Schmidt, Saliba, T., Kabani, A., J. Mogridge. (2004) Development and characterization of monoclonal antibody to recombinant PA toxin of Bacillus anthracis International Conference of Immunology (12th), Montreal, July 18-23.

Berry, J.D., Tsang, RT., Jones, S., Sabara, M., Andonov, A., Drebot, M., Nagata, L., Yuan, XY., Nicolas, B, Clavijo, A., Kitching, P., McClarty , D., Plummer, F., Kabani, A. 2003. Monoclonal Antibody Development to agents of Foreign Animal Disease, BioTerrorism Agents, and Emerging Infectious Threats: A centralized approach to Diagnostic and Therapeutic antibody Development. Biodefense 2003, Washington D.C., August 27-28.

Bilenki L. and X. Yang. Chlamydia trachomatis infection inhibits the development of airway eosinophilia induced by ragweed. Canadian Society for Immunology annual meeting, April 2001, Banff, Alberta

Bilenki L. and X. Yang. IL-10-producing dendritic cells display alterred Toll-like receptor (TLR) expression and contribute to infection-mediated inhibition of RW-driven allergic responses. CIM 27:147A, 2004

Bilenki L. and X. Yang. Inhibition of ragweed induced airway eosinophilic inflammation by chlamydial infection. Keystone Symposia: hygiene, allergy and asthma, Keystone, Colorado, April 2003

Bilenki L. and X. Yang. Natural killer T (NKT) cells contribute to airway eosinophilic inflammation in a murine model of asthma-like reaction induced by ragweed. Nov 2002, Quebec city, Quebic